Epignostix

Cancer classification you can act on We combine leading scientific and medical expertise with innovative technology to improve diagnostic accuracy and enhance clinical care for cancer patients.

Health and bio

Latest funding

Seed · July 2, 2024

Amount not disclosed in a source on record.

Funding history ↓

Website: epignostix.com.

Category: Health and bio.

Stage: Seed.

Last round: Jul 2, 2024 · 863 days ago.

On Recent Funding since: Nov 8, 2026.

Signals

Website registeredFeb 19, 2022 (4 years old)

About Epignostix

Learn more What we enable Enabling cancer diagnostics and precision oncology

Funding rounds

July 2, 2024
Seed · amount undisclosed
Source: fundraisingfox.com
February 19, 2022
Website created

Founders and team

DS
Daniel Schrimpf Head of Software Development & Co-founder

source: epignostix.com
DJ
David Jones Chief Scientific Officer & Co-founder

source: epignostix.com
FS
Felix Sahm Chief Medical Advisor & Co-founder

source: epignostix.com
MS
Martin Sill Head of Data Science & Co-founder

source: epignostix.com

Companies like Epignostix

PProvision SurgicalPre Seed · Sep 2026
DDandelion Health$14M Series A · May 2026
DDigital Diagnostics$75M Series B+ · Aug 2022
BBIOMAKERSSeries A · Jul 2026
CCarez AI
VValius SciencesSeed · Apr 2026

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/epignostix (get a free API key).